✦ LIBER ✦

Electrophysiologic effects of the calcium antagonist isradipine, a double-blind placebo-controlled study

✍ Scribed by V. Kühlkamp; F. Maier; L. Seipel

Book ID: 119123111
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 477 KB
Volume: 30
Category: Article
ISSN: 0167-5273
DOI: 10.1016/0167-5273(91)90098-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No Effect of the Calcium Antagonist, Isr

No Effect of the Calcium Antagonist, Isradipine, on Plasma Catecholamines in Irreversible Chronic Obstructive Pulmonary Disease (COPD). A Randomized, Double-blind, Placebo-controlled Study

✍ Niels A. Graudal; Anders M. Galløe; Inger Plum; Nils Milman; Jesper O. Clausen 📂 Article 📅 1995 🏛 Elsevier 🌐 English ⚖ 243 KB

SUMMARY: Calcium antagonists have been claimed to decrease the pulmonary artery pressure and increase oxygen uptake and cardiac output in patients with chronic obstructive pulmonary disease (COPD). This should tend to decrease the plasma levels of catecholamines. The purpose of the present study was

Effects of menatetrenone on the bone and

Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study

✍ Hajime Orimo; Masataka Shiraki; Akio Tomita; Hirotoshi Morii; Takuo Fujita; Masa 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 159 KB

A Double-Blind, Placebo-Controlled Study

A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania

✍ Jon E. Grant; Suck Won Kim; Brian L. Odlaug 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Barnidipine, a Novel Calcium Antagonist

Barnidipine, a Novel Calcium Antagonist for Once-Daily Treatment of Hypertension: A Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging Study

✍ Wimpeter Hart; Nicolas J. Holwerda 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 177 KB

The effect of the calcium antagonist, is

The effect of the calcium antagonist, isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double-blind, placebo-controlled study

✍ A. M. GALLØE; N. GRAUDAL; J. R. PETERSEN; P. LETH; M. GALLØE 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

✍ N. Barnes; I. Pavord; A. Chuchalin; J. Bell; M. Hunter; T. Lewis; D. Parker; M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB